MEGAN HAWKINS: Open Payments
NPI 1841691557 · FISHERS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$774 in 41 payments from 14 companies in 2025. Trend: 2023 $211 · 2024 $685 · 2025 $774
Food & beverage: $774
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $254 |
| Astellas Pharma US Inc | 4 | $86 |
| PFIZER INC. | 5 | $80 |
| Abbott Laboratories | 3 | $68 |
| Lilly USA, LLC | 3 | $59 |
| Corium, LLC | 2 | $40 |
| ABBVIE INC. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Phathom Pharmaceuticals, Inc. | 2 | $26 |
| RGH Enterprises LLC | 1 | $22 |
Products named: Wegovy, Veozah, FREESTYLE LIBRE 3, MOUNJARO, NURTEC ODT, Ozempic, Azstarys, LINZESS.
Industry payments across IN — which companies pay providers there.
